Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction

Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Blood samples from 249 co...

Full description

Saved in:

Bibliographic Details
Published in:	Arteriosclerosis, thrombosis, and vascular biology Vol. 28; no. 5; p. 954
Main Authors:	Zeller, Marianne, Korandji, Claudia, Guilland, Jean-Claude, Sicard, Pierre, Vergely, Catherine, Lorgis, Luc, Beer, Jean-Claude, Duvillard, Laurence, Lagrost, Anne-Cécile, Moreau, Daniel, Gambert, Philippe, Cottin, Yves, Rochette, Luc
Format:	Journal Article
Language:	English
Published:	United States 01.05.2008
Subjects:	Aged Aged, 80 and over Arginine - analogs & derivatives Arginine - blood Biomarkers - blood Cohort Studies Female Follow-Up Studies Humans Male Middle Aged Myocardial Infarction - blood Myocardial Infarction - mortality Predictive Value of Tests Prognosis Prospective Studies Regression Analysis
ISSN:	1524-4636, 1524-4636
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!